Raymond James Financial Services Advisors, Inc. Seagen Inc. Transaction History

Raymond James Financial Services Advisors, Inc.

$73.5 Billion
Q3 2024

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 24, 2023	BUY	$191.51 - $216.16 $130,418 - $147,204	681 Added 5.22%	13,720 $2.91 Million
Q2 2023 Jul 25, 2023	BUY	$187.64 - $206.25 $937,637 - $1.03 Million	4,997 Added 62.14%	13,039 $2.51 Million
Q1 2023 Apr 14, 2023	SELL	$127.59 - $203.08 $27,049 - $43,052	-212 Reduced 2.57%	8,042 $1.63 Million
Q4 2022 Feb 08, 2023	SELL	$117.37 - $139.17 $220,186 - $261,082	-1,876 Reduced 18.52%	8,254 $1.06 Million
Q3 2022 Oct 25, 2022	SELL	$135.27 - $180.11 $142,304 - $189,475	-1,052 Reduced 9.41%	10,130 $1.39 Million
Q2 2022 Aug 12, 2022	BUY	$108.81 - $179.33 $421,856 - $695,262	3,877 Added 53.07%	11,182 $1.98 Million
Q1 2022 May 11, 2022	SELL	$119.61 - $157.85 $40,188 - $53,037	-336 Reduced 4.4%	7,305 $1.05 Million
Q4 2021 Feb 08, 2022	SELL	$142.57 - $190.86 $177,784 - $238,002	-1,247 Reduced 14.03%	7,641 $1.18 Million
Q3 2021 Nov 02, 2021	BUY	$142.45 - $169.82 $1,566 - $1,868	11 Added 0.12%	8,888 $1.51 Million
Q2 2021 Aug 11, 2021	SELL	$135.08 - $161.1 $48,223 - $57,512	-357 Reduced 3.87%	8,877 $1.4 Million
Q1 2021 May 14, 2021	SELL	$137.51 - $190.8 $337,724 - $468,604	-2,456 Reduced 21.01%	9,234 $1.28 Million
Q4 2020 Feb 12, 2021	BUY	$164.63 - $211.93 $1.92 Million - $2.48 Million	11,690 New	11,690 $2.05 Million

Others Institutions Holding SGEN

# of Institutions

Shares Held

1.26M

Call Options Held

23K

Put Options Held

55.2K

View Full List

About Seagen Inc.

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

More about SGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.

Account